Skip to main content
. 2006 Mar 9;108(1):123–133. doi: 10.1182/blood-2005-11-4458

Table 1.

Down-regulation of splenic erythroblast cell-surface Fas/FasL in ts-VHL−/− mice

Subset frequency, % of Ter 119+ cells
Fas-positive cells, %
FasL-positive cells, %
Control*; n = 6 ts-VHL −/−; n = 5 P Control*; n = 6 ts-VHL −/−; n = 5 P Control*; n = 6 ts-VHL −/−; n = 5 P
Spleen
ProE 0.6 ± 0.2 1.5 ± 0.3 38 ± 9 9 ± 3 .023 66 ± 4 36 ± 9 .025
Ery.A 24 ± 5 36 ± 3 .044 48 ± 6 26 ± 3 .011 79 ± 2 60 ± 5 .018
Ery.B 24 ± 4 39 ± 3 .012 12 ± 1 3 ± 0.4 < .001 37 ± 4 12 ± 4 .002
Ery.C 52 ± 8 24 ± 4 .045 0.6 ± 0.1 0.3 ± 0.1 1 ± 0.2 0.6 ± 0.2
Non-Ery NA NA 47 ± 4 47 ± 6 10 ± 0.2 9 ± 1
Bone marrow
ProE 1.9 ± 0.3 2.0 ± 0.4 21 ± 3 13 ± 3 35 ± 4 28 ± 5
Ery.A 35 ± 4 35 ± 5 21 ± 2 17 ± 4 51 ± 3 41 ± 4
Ery.B 34 ± 2 25 ± 1 .001 2 ± 0.5 1 ± 0.2 9 ± 2 6 ± 2
Ery.C 29 ± 4 38 ± 6 0.3 ± 0.05 0.3 ± 0.1 0.6 ± 0.1 0.3 ± 0.1
Non-Ery NA NA 51 ± 4 50 ± 3 15 ± 4 18 ± 5

Non-Ery indicates nonerythroid; NA, not applicable; and —, not significant.

*

Matched littermates, number of mice indicated (n).

Two-tailed Student t test, unequal variance, only for statistically significant differences at P < .05.